Jamjoom Pharma Reports SAR 305.84M Net Profit in the Six Months 2026
JAMJOOM PHARMA 4015.SA | 0.00 |
On 2026-07-22 08:02:20 (Saudi Time), Jamjoom Pharmaceuticals Factory Co. announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 445.31 | 396.22 | 12.389 | 481.38 | -7.493 |
| Gross Profit (Loss) | 293.65 | 250.8 | 17.085 | 310.38 | -5.39 |
| Operational Profit (Loss) | 146 | 135.35 | 7.868 | 172.38 | -15.303 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 137.63 | 132.02 | 4.249 | 168.21 | -18.179 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 148.65 | 135.27 | 9.891 | 152.84 | -2.741 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 926.7 | 853.75 | 8.544 |
| Gross Profit (Loss) | 604.03 | 543.64 | 11.108 |
| Operational Profit (Loss) | 318.37 | 293.53 | 8.462 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 305.84 | 289.06 | 5.805 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 301.49 | 293.38 | 2.764 |
| Total Shareholders Equity (after Deducting Minority Equity) | 1,878.25 | 1,681.79 | 11.681 |
| Profit (Loss) per Share | 4.37 | 4.13 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| Accumulated Losses | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For the six-month period ending 30 June 2026, Jamjoom Pharmaceuticals' revenue rose 8.544% YoY to SAR 926.7 million, driven by higher volumes, a favorable product mix across strategic brands, and sales growth across key markets. Net profit attributable to shareholders increased 5.805% YoY to SAR 305.84 million, supported by revenue growth and gross-margin expansion, but partially offset by higher operating expenses stemming from increased commercial hiring and promotional activity, an adverse foreign-exchange impact compared with a gain in the prior-year period, and a lower share of profit from the Joint Venture.
Quarter-on-Quarter Performance Drivers
QoQ revenue declined 7.5% to SAR 445.31 million, as Q1 is seasonally stronger due to a higher number of deliveries at the start of the year. Net profit fell 18.2% to SAR 137.63 million, driven by the lower revenue base combined with higher selling and distribution expenses stemming from increased commercial hiring and promotional activity during the quarter.
Other Items
The external auditor issued an unmodified conclusion with no additional comments or reservations noted. No accumulated losses or fair value changes on investment properties were reported. No material risks, going concern issues, or debt covenant breaches were disclosed in this announcement.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96921&anCat=1&cs=4015&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/16392_4526_2026-07-21_23-28-21_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.